hydrocodone (HYSINGLA ER, NORCO, VANTRELA ER, ZOHYDRO ER, ZOHYRDRO)
acetaminophen and codeine (TYLENOL WITH CODEINE); acetaminophen and hydrocodone (ANEXSIA, BANCAP-HC, HYDROGESIC, LORTAB, PROCET, VICODIN); acetaminophen and oxycodone (OXYCET, PERCOCET, ROXICET, TYLOX, XARTEMIS XR); aspirin and oxycodone (PERCODAN); codeine; hydrocodone (HYSINGLA ER, NORCO, VANTRELA ER, ZOHYDRO ER, ZOHYRDRO); hydrocodone and ibuprofen (REPREXAIN, VICOPROFEN); hydromorphone (DILAUDID, DILUDID-5, EXALGO); meperidine (DEMEROL); morphine (ARYMO ER, KADIAN, MORPHABOND ER, MS CONTIN, ROXANOL); oxycodone (OXAYDO, OXYCONTIN, ROXICODONE, ROXICODONE INTENSOL, XTAMPZA ER)
How to Dispose of Unused Opioids and Other High-Risk Drugs Safely [hide all summaries]
Unused, unneeded or expired drugs in homes present a number of risks, including intentional or accidental overdose in humans (particularly young children). Learn how to safely dispose of these drugs.
FDA Warns Against Use of Opioid-Containing Cough and Cold Medications in Children [hide all summaries]
In this article, we review the dangers of using opioid-containing cough and cold medicines in children younger than age 18.
Owner of Drugmaker Linked to Meningitis Outbreak Convicted of Racketeering But Acquitted of Murder [hide all summaries]
In March 2017, a federal jury found the co-owner of a now-bankrupt Massachusetts compounding pharmacy guilty on more than 50 counts of racketeering and mail fraud for his role in the deadly nationwide fungal meningitis outbreak in 2012, which had been linked to tainted steroid drugs. Read the troubling details of how the company's co-owner escaped being convicted of second-degree murder.
Drugs That Are Most Likely to Land Patients in the Emergency Room [hide all summaries]
Many adverse drug reactions are severe enough to cause serious injury, hospitalization and even death. Find out which outpatient medications are most likely to cause adverse events that necessitate a visit to the emergency room.
News Brief for November 2016 [hide all summaries]
In this month's News Brief section, we report on action taken by the Food and Drug Administration to add important new warnings to the labeling of all opioid and benzodiazepines drugs.
News Brief for August 2016 [hide all summaries]
In this month's news briefs, we report on the FDA's decision to require new black-box warnings in the labeling of all immediate-release opioid drugs about the risks of abuse, addiction, overdose and death, as well as the agency's recent drug safety alert reminding consumers not to purchase over-the-counter chelation products. We also discuss the decision of a major drugmaker to terminate its involvement in the marketing of an inhaled form of insulin.
Long-Acting Opioids: Extra Caution Needed [hide all summaries]
In this article, we review new evidence suggesting that long-acting opioids are associated with a higher risk of unintentional life-threatening over¬doses than short-acting forms of these drugs.
Drugs That Cause Hearing Problems [hide all summaries]
For most people with hearing loss, the condition likely is age-related or due to long-term exposure to loud noise. But for some patients, the cause of the problem can be found in the medicine cabinet. Learn about some commonly used medications that can cause hearing disorders.
News Brief for March 2015 [hide all summaries]
In our news brief this month, we report on the FDA's recent approval of a new, high-dose, extended-release formulation of the opioid drug oxycodone (HYSLINGA). Although this new version of the drug is designed to deter abuse, it may be more dangerous than other oxycodone products. Read this article to find out why.
The FDA Must Restrict the Use of Prescription Narcotic Hydrocodone [hide all summaries]
Find out why the most commonly prescribed drug of any kind in the U.S., hydrocodone, needs tighter restrictions to prevent emergency room visits, overdose deaths and other serious consequences of its massive overuse. Production and use of hydrocodone in this country amounts to 99 percent of that for the entire world. Is the rest of the world wrong and we are right?
FDA Should Change Labels On Opioid Painkillers to Deter Misprescribing [hide all summaries]
The article reviews a recent petition to the FDA seeking improvements on the labels of prescription opioids (narcotics). The label change would prevent drug companies from promoting these drugs for noncancer pain for dangerously long periods of time, at doses that are too high, and for uses other than severe pain in noncancer patients. The petition was signed by 37 public health experts, including leaders in the fields of pain medicine, addiction and primary care; the health commissioners of New York City and New York state; and Dr. Sidney Wolfe, director of Public Citizen's Health Research Group.
Oxycodone: Be Careful What You Take With It [hide all summaries]
The article lists 24 drugs that can increase the toxicity of oxycodone if taken together with the drug and 11 other drugs that can weaken its effectiveness as a painkiller if they are simutaneously used.
Testimony to Drug Safety and Risk Management Advisory Committee on Overprescription of Hydrocodone (HRG Publication #2092) [hide all summaries]
Ninety-nine percent of the hydrocodone in the world is manufactured and used in the United States – evidence that hydrocodone products are being overprescribed and should be severely restricted, Public Citizen told the FDA today.
SHOW secondary search results for hydrocodone (HYSINGLA ER, NORCO, VANTRELA ER, ZOHYDRO ER, ZOHYRDRO)